Envista Holdings Corp. (NVST) News
Filter NVST News Items
NVST News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
NVST News Highlights
- For NVST, its 30 day story count is now at 5.
- Over the past 10 days, the trend for NVST's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- DSKE, LINK and PRE are the most mentioned tickers in articles about NVST.
Latest NVST News From Around the Web
Below are the latest news stories about ENVISTA HOLDINGS CORP that investors may wish to consider to help them evaluate NVST as an investment opportunity.
New Strong Sell Stocks for December 21stDSKE, NVST and HENKY have been added to the Zacks Rank #5 (Strong Sell) List on December 21, 2023. |
Envista Announces Participation in J.P. Morgan Healthcare ConferenceEnvista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 3:00 – 3:40 PM PST. There will be an audio-only recording link that can be viewed on Envista's Investor Relations website for up to 30 days post event. |
Envista Holdings Corporation Appoints Three New Members to Leadership TeamEnvista Holdings Corporation (NYSE: NVST) today announced the expansion of its leadership team, with the recent appointments of Robert Befidi as President, Diagnostics; Suraj Satpathy as Chief Human Resources Officer; and Andrew Chen as Chief Information Officer. |
Envista Holdings Corporation's (NYSE:NVST) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?It is hard to get excited after looking at Envista Holdings' (NYSE:NVST) recent performance, when its stock has... |
Envista cut to Sell at Goldman Sachs, CRISPR to Underperform: 4 big analyst cutsHere is your Pro Recap of the biggest analyst cuts you may have missed today: downgrades at Envista, CRISPR Therapeutics, Super Micro Computer, and Vornado Realty Trust. Envista (NYSE:NVST) shares dropped more than 2% pre-market today after Goldman Sachs downgraded the company to Sell from Neutral with a price target of $22.00. |
Envista (NVST) Up 6.8% Since Last Earnings Report: Can It Continue?Envista (NVST) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Artisan Partners Small Cap Fund Sold Envista Holdings Corporation (NVST) as It’s an Ill-Timed Investment?Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. In the third quarter, its Investor Class fund ARTSX returned -7.98%, Advisor Class fund APDSX posted a return of -7.96%, and Institutional Class fund APHSX returned -7.97%, compared to a […] |
15 Best Countries for Dental ImplantsIn this article, we will look at the 15 best countries for dental implants. We have also discussed the cost and success of dental implants. If you want to skip our detailed analysis, head straight to the 5 Best Countries for Dental Implants. What are Dental Implants, and How Successful Are They? Dental implant surgery […] |
Top 15 Countries With Best Dental HealthIn this article, we will look at the top 15 countries with best dental health. We will also discuss the state of dental care around the world. If you want to skip our detailed analysis, head straight to the Top 5 Countries With Best Dental Health. Oral diseases represent a major global health challenge and […] |
Envista Announces Release of 2022 Sustainability ReportEnvista Holdings Corporation (NYSE: NVST) today announced the release of its 2022 Sustainability Report, detailing its efforts to incorporate environmental, social, and governance (ESG) considerations into its mission to digitize, personalize, and democratize dental care. The full report can be found HERE. |